Catamaran Bio Announces Appointment of Dr Alvin Shih as President and Chief Executive Officer financialbuzz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialbuzz.com Daily Mail and Mail on Sunday newspapers.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Catamaran Bio Announces Appointment of Dr. Alvin Shih as President and Chief Executive Officer
February 4, 2021 GMT
Catamaran CEO Alvin Shih (Photo: Business Wire)
CAMBRIDGE, Mass. (BUSINESS WIRE) Feb 4, 2021
Catamaran Bio, Inc., a biotechnology company developing allogeneic CAR-NK cell therapies to treat diseases with significant unmet medical need, today announced the appointment of Alvin Shih, MD, MBA, as President and Chief Executive Officer. He has concurrently been appointed to the Board of Directors for Catamaran. Dr. Shih is an experienced biopharma executive with a track record of success in building companies across a broad spectrum of disease areas and therapeutic modalities, including cell and tissue therapies.
Kate Bingham put her role as a life-sciences venture capitalist on hold last July when she was approached by Prime Minister Boris Johnson to head up the UK s Vaccine Taskforce (VTF).
A year into the pandemic despite limited buying power the UK has secured deals for 407 million doses of COVID-19 vaccine from several companies, according to the government.
As of February 1, 13.7% of the country s population has had at least a first dose of the two-part Pfizer vaccine, according to The Times of London outstripping progress in the US and European Union.
In the US, President Joe Biden s administration is hurrying to bring order to his predecessor s patchwork, state-by-state vaccine distribution effort that saw the country finish 2020 far short of its vaccination goal.
400+ Investors, Innovators and Strategics Confirmed For LSI 2021 Emerging Medtech Summit in Southern California
New Dates, May 11-13, Virtual Options and Keynote Speakers Announced
News provided by
Share this article
Share this article
LOS ANGELES, Jan. 25, 2021 /PRNewswire/ Life Science Intelligence (LSI) announced today that more than 400 innovators, strategics and investors have registered for the Emerging Medtech Summit, which will be held May 11-13, at The Ritz-Carlton, Laguna Niguel Hotel in the beachside community of Dana Point in Southern California. Key speakers have also been announced, including Paul LaViolette, Managing Partner, SV Health Investors, Scott Huennekens, Executive Chairman, Acutus and Christopher Velis, Founder & Executive Chairman, Miraki Innovation.
Health tech giant Hillrom to acquire Seattle startup Bardy Diagnostics for $375M
January 19, 2021 at 10:31 am
Dr. Gust Bardy, founder of Bardy Diagnostics. (Bardy Photo)
Hillrom, a publicly-traded medical device and digital health company based in Chicago, will pay $375 million to acquire Seattle startup Bardy Diagnostics.
Founded in 2013, Bardy set out to change the way medical professionals monitor heart conditions with a non-invasive cardiac monitor patch that helps detect arrhythmia. The Carnation Ambulatory Monitor, or CAM for short, is designed to be worn comfortably for approximately a week, with the goal of improving patient compliance. It uses a unique circuit design and algorithms to process P-wave recording. Bardy claims that its device captures clearer and more accurate heart rhythms than competing electrocardiography (ECG) monitors.